Skip to main content

UNC Urology has once again solidified its reputation as a leader in academic research, ranking 28th nationally and 14th among public universities in National Institutes of Health (NIH) research funding for 2024, according to the latest Blue Ridge Institute for Medical Research (BRIMR) report.

UNC Urology’s ranking is part of a broader success story for the UNC School of Medicine, which ranked 7th among public medical schools and 19th overall in total NIH funding, receiving more than $349 million in research grants in 2024. This funding plays a crucial role in driving discovery across multiple medical disciplines, including cancer research, biomedical engineering, and genetics.

Read the UNC School of Medicine’s Announcement here.

North Carolina’s Strength in Medical Research

Beyond institutional rankings, North Carolina continues to be a hub for medical innovation. The state ranks among the top in per capita NIH funding (6th highest in the Nation), reflecting its robust research infrastructure and commitment to advancing healthcare. Within the state, Chapel Hill is a key contributor, with UNC-Chapel Hill’s research enterprises receiving a significant share of NIH funding (20th largest among all cities). Durham and The Research Triangle Park also made the list at 14th, and 23rd respectively, reinforcing the region as a national leader in biomedical and clinical research

Urology Specialty Recognition

The specialty of Urology has seen remarkable growth in research funding nationwide, supporting studies in urologic cancers, kidney disease, and innovative surgical techniques. UNC Urology’s ranking within the top 30 departments nationally (28th overall, 14th among public medical schools) speaks to its dedication to cutting-edge research and its role in shaping the future of urologic care.

 

“This ranking is a testament to the dedication of our faculty, researchers, and staff who work tirelessly to push the boundaries of knowledge in urology. NIH funding allows us to conduct groundbreaking studies that ultimately improve outcomes for patients not just in North Carolina, but across the nation.”

Matthew Nielsen, MD, MS, FACS
Professor and Chair of Urology

Matthew Nielsen, MD, MS, FACS